Skip to content

Author

M. Kontić

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

When Brain Metastases Meet Immunotherapy: Real-World Outcomes With First-Line Pembrolizumab in PD-L1-High Metastatic NSCLC

Background: Although immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape for patients with non-small cell lung cancer (NSCLC), the impact on brain metastases (BM) remains uncertain, as these patients have often been excluded from or underrepresented in clinical trials. The aim of this study w...

A. Ratkovic, N. Nikolić, A. Golubovic et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.